Name: SELLAS Life Sciences Group, Inc. (SLS) Balance Sheet
Creator: FinSpry

SELLAS Life Sciences Group Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for SELLAS Life Sciences Group, Inc. (SLS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	13.89	2.53	17.13	21.36	35.30	7.38	5.34
Cash & Short-Term Investments	13.89	2.53	17.13	21.36	35.30	7.38	5.34
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.44	0.14	0.30	0.03	1.13	0.30	0.13
Total Current Assets	16.33	3.17	17.76	23.04	36.93	8.23	5.84
Non-Current Assets
Property, Plant & Equipment (Net)	0.93	0.86	0.87	0.72	0.90	0.22	0.00
Goodwill	1.91	1.91	1.91	1.91	1.91	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.00	5.70	0.00	0.00
Other Non-Current Assets	0.27	0.28	0.40	0.59	0.61	0.00	0.00
Total Non-Current Assets	3.11	3.03	3.19	3.23	9.12	8.35	11.08
Total Assets	19.43	6.22	20.94	26.28	46.05	16.59	16.92
Current Liabilities
Accounts Payable	3.50	5.64	3.36	2.14	6.57	5.07	5.29
Short-Term Debt	0.54	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	3.65	7.61	6.29	1.49	1.72	0.00	0.00
Deferred Revenue	0.00	0.00	0.00	0.00	5.60	0.00	0.00
Other Current Liabilities	0.04	0.04	5.50	0.16	0.81	0.00	0.01
Total Current Liabilities	9.51	13.74	15.52	4.98	12.34	10.20	5.97
Non-Current Liabilities
Long-Term Debt	0.46	0.46	0.57	0.61	0.83	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.24	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.30	9.50	0.00	4.33
Total Non-Current Liabilities	0.46	0.46	0.58	0.95	1.12	0.31	5.70
Total Liabilities	9.97	14.20	16.09	5.93	18.09	10.52	11.67
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-248.13	-217.24	-179.90	-138.60	-117.90	-101.15	-81.86
Additional Paid-in Capital	257.58	209.27	184.75	158.95	145.86	107.24	87.10
Shares Outstanding	73.98	32.13	21.01	15.90	0.00	0.00	0.00
Total Stockholders' Equity	9.47	-7.98	4.85	20.35	27.96	6.09	5.25
Total Liabilities & Equity	19.43	6.22	20.94	26.28	46.05	16.59	16.92